biomarker

  1. Chandelier

    Multi-omic analysis of post-acute sequelae of COVID-19 (PASC), 2026, Beimers et al.

    Multi-omic analysis of post-acute sequelae of COVID-19 (PASC) Abstract Millions of patients surviving COVID-19 infection develop post-acute sequelae of COVID-19 (PASC), a debilitating condition that severely disrupts quality of life. Limited data exists on PASC patient peripheral blood...
  2. Chandelier

    Oral Fluid Inflammatory Biomarker Profile in LC: Evaluation of Oral Active and Total MMP-8, MMP-9, and TIMP-1 in Relation to BMI…, 2026, Seno Aji+

    Oral Fluid Inflammatory Biomarker Profile in Long COVID: Evaluation of Oral Active and Total MMP-8, MMP-9, and TIMP-1 in Relation to BMI and Disease Status Abstract Background Long COVID (LC) is characterized by persistent systemic symptoms, but its oral inflammatory profile remains unclear...
  3. Chandelier

    Severity-associated endothelial dysfunction in post-COVID-19 patients: flow-mediated dilation and vasoactive biomarkers, 2026, Palii et al.

    Severity-associated endothelial dysfunction in post-COVID-19 patients: flow-mediated dilation and vasoactive biomarkers Abstract COVID-19 is frequently associated with endothelial dysfunction, characterized by an imbalance between vasodilatory and vasoconstrictive mediators. This study...
  4. Chandelier

    Long COVID shows IL-1 pathway dysregulation without a discrete circulating biomarker signature, 2026, Muñoz-López et al.

    Long COVID shows IL-1 pathway dysregulation without a discrete circulating biomarker signature Abstract Long COVID (LC) is characterized by persistent and, often, disabling symptoms, yet its biological basis remains unclear. Multiple mechanisms, including immune dysregulation, endothelial...
  5. Chandelier

    Serum Cu/Zn ratio is significantly associated with long COVID, 2026, Takayasu et al.

    Serum Cu/Zn ratio is significantly associated with long COVID Abstract Since the coronavirus disease 2019 (COVID-19) pandemic, many people have been affected by COVID-19. However, at present, neither reliable predictors of long COVID nor effective treatments are widely established. The aim...
  6. Chandelier

    Beyond genes: EpiSwitch® & Orion platform-powered 3D genome architecture biomarkers reveal shared biology across ME/CFS, LC, PTSD, RA&MS, 2026, Hunter

    Beyond genes: EpiSwitch® and Orion platform-powered 3D genome architecture biomarkers reveal shared biology across ME/CFS, long COVID, PTSD, rheumatoid arthritis, and multiple sclerosis Abstract Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long COVID (LC19)...
  7. Chandelier

    Searching for biomarkers of long COVID: findings from a nationwide population-based study, 2026, Helmsdal et al.

    Searching for biomarkers of long COVID: findings from a nationwide population-based study Abstract Long COVID, characterized by persistent symptoms following SARS-CoV-2 infection, affects an estimated 400 million people worldwide. The absence of reliable biomarkers has hindered progress...
  8. Chandelier

    Circulating Drivers of Pathophysiology in Post-COVID-19 Sequelae, 2026, Abdullah et al.

    Circulating Drivers of Pathophysiology in Post-COVID-19 Sequelae Abstract Introduction: According to the WHO, post-COVID-19 sequelae impose an increased burden of illness and comorbidities among survivors. The present study evaluated systemic clinical complications associated with the...
  9. Chandelier

    Clinical-cognitive profiles in long COVID and their associations with inflammatory-endothelial biomarkers and vascular measures, 2026, Arjol et al.

    Clinical-cognitive profiles in long COVID and their associations with inflammatory-endothelial biomarkers and vascular measures Abstract Long COVID is clinically heterogeneous, and reproducible biomarker patterns remain limited. This cross-sectional study aimed to identify clinical-cognitive...
  10. Chandelier

    Circulating MicroRNA ratios as diagnostic biomarkers for long COVID with an independent validation cohort, 2026, Han et al.

    Circulating MicroRNA ratios as diagnostic biomarkers for long COVID with an independent validation cohort Abstract Background Long COVID is a multisystemic condition with heterogeneous clinical presentations lacking diagnostic biomarkers with discriminatory capacity. This study screened...
  11. Chandelier

    Long-term angiogenic and thromboinflammatory signatures in post-COVID-19 syndrome, 2026, Mora Zetina et al.

    Long-term angiogenic and thromboinflammatory signatures in post-COVID-19 syndrome Abstract Background Post-COVID-19 syndrome is a major long-term sequela of severe SARS-CoV-2 infection, potentially involving persistent angiogenic and thromboinflammatory dysfunction, though long-term biomarker...
  12. forestglip

    Biomarkers of long COVID in children and young adults: a scoping review, 2026, Camara et al

    Biomarkers of long COVID in children and young adults: a scoping review Bettina Camara, Danilo Buonsenso Abstract Following the SARS-CoV-2 pandemic, a significant percentage of people are now experiencing long-term symptoms, despite a continuing lack of concrete documentation of physiological...
  13. SNT Gatchaman

    A multi-omics recovery factor predicts long COVID in the IMPACC study, 2026, Gabernet et al.

    Now published - see here Preprint Identification of a multi-omics factor predictive of long COVID in the IMPACC study Gisela Gabernet; Jessica Maciuch; Jeremy P Gygi; John F Moore; Annmarie Hoch; Caitlin Syphurs; Tianyi Chu; Naresh Doni Jayavelu; David B Corry; Farrah Kheradmand; Lindsey R...
  14. Nightsong

    Review The search for a blood-based biomarker for [ME/CFS]: from biochemistry to electrophysiology, 2025, Clarke et al

    Abstract Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disease of unknown aetiology characterised by symptoms of post-exertional malaise (PEM) and fatigue leading to substantial impairment in functioning. Other key symptoms include cognitive impairment and...
  15. Sly Saint

    Accurate detection of acute sleep deprivation using a metabolomic biomarker—A machine learning approach 2024

    Abstract Sleep deprivation enhances risk for serious injury and fatality on the roads and in workplaces. To facilitate future management of these risks through advanced detection, we developed and validated a metabolomic biomarker of sleep deprivation in healthy, young participants, across three...
  16. Sly Saint

    Article: Revolutionising Biomarker Discovery: The Role of High-Performance Liquid Chromatography

    full article Revolutionising Biomarker Discovery: The Role of High-Performance Liquid Chromatography
  17. Sly Saint

    Proteomics International Laboratories Ltd (ASX:PIQ) Breakthrough Results For Endometriosis Diagnostic Blood Test

    Proteomics International Laboratories Ltd (ASXIQ) Breakthrough Results For Endometriosis Diagnostic Blood Test
  18. Wyva

    Discriminating Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and comorbid conditions using metabolomics in UK Biobank, 2024, Huang et al

    Katherine Huang, Alex G. C. de Sá, Natalie Thomas, Robert D. Phair, Paul R. Gooley, David B. Ascher & Christopher W. Armstrong Abstract Background Diagnosing complex illnesses like Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is complicated due to the diverse symptomology and...
  19. Wyva

    Immunometabolic changes and potential biomarkers in CFS peripheral immune cells revealed by single-cell RNA sequencing, 2024, Sun et al

    Abstract The pathogenesis of Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) remains unclear, though increasing evidence suggests inflammatory processes play key roles. In this study, single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) was used to...
  20. forestglip

    Plasma biomarkers in chronic single moderate–severe traumatic brain injury, 2024, Spitz et al

    Plasma biomarkers in chronic single moderate–severe traumatic brain injury Gershon Spitz, Amelia J. Hicks, Stuart J. McDonald, Vincent Dore, Natasha Krishnadas, Terence J. O’Brien, William T O’Brien, Lucy Vivash, Meng Law, Jennie L. Ponsford, Christopher Rowe, Sandy R. Shultz Abstract Blood...
Back
Top Bottom